Studies demonstrate that blocking γδ T cells, IL-17a, or IL-21 confers significant neuroprotective effects against ischemic brain injury in murine stroke models, establishing them as promising therapeutic targets for mitigating ischemic brain damage (109, 193). This evidence concerns the gene IL17A and brain injury.